IXHL Incannex Healthcare Inc.

-

Incannex Healthcare Beat Consensus Estimates

Friday, May 15, 2026 · 12:00 AM ET

Incannex Healthcare (IXHL) reported a loss of $0.35 per share on revenue of $0.00 million for the fiscal third quarter ended March 2026. The consensus estimate was a loss of $0.60 per share on revenue of $40.00 million. The company beat consensus estimates by 41.67%.

Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.35)
Earnings Whisper®
Consensus Estimate
($0.60)
Earnings Surprise
Earnings Growth-45.8 %
Reported Revenue
Revenue Estimate
$40.00M
Revenue Surprise
Revenue Growth